Part,  Chapter, Paragraph

 1    -,     1        |         information to facilitate the identification of priority issues for future
 2    I,     2.Acr    |         Genomics~RFID~Radio Frequency Identification~SMEs~Small and medium-sized
 3    I,     2. 10.  3|             debate on radio frequency identification (RFID) and issuing of policy
 4    I,     2. 10.  4|                     2.10.4. Automatic identification and traceability technologies~ ~
 5    I,     2. 10.  4|          bar-codes or radio frequency identification (RFID) allow automatic identification
 6    I,     2. 10.  4| identification (RFID) allow automatic identification and data capture of pharmaceutical
 7    I,     2. 10.  4|              a lower cost than manual identification alone.~ ~Automatic identification
 8    I,     2. 10.  4|     identification alone.~ ~Automatic identification systems have a very wide
 9    I,     2. 10.  4|           make also feasible a unique identification for each and every pack
10    I,     2. 10.  4|             have shown that automatic identification throughout the entire Healthcare
11    I,     2. 10.  4|              introduction of a unique identification for drugs or medical device,
12    I,     2. 10.  4|              consumption. This unique identification can then be crosschecked
13    I,     2. 10.  4|              of all need a legitimate identification number that is registered
14    I,     2. 10.  4|       hospital budgets18.~ ~Automatic identification and traceability systems
15    I,     2. 10.  4|         process and automatic product identification in the San Raffaele Scientific
16    I,     2. 10.  4|             availability of automatic identification systems in hospitals today
17    I,     2. 10.  4|              penetration of automatic identification technologies is higher with
18    I,     2. 10.  4|               necessary for automatic identification until manufacturers routinely
19    I,     2. 10.  4|         benefits related to automatic identification and traceability systems.
20    I,     2. 10.  4|              border trading, a global identification number can be used to identify
21    I,     2. 10.  4|           various local requirements. Identification numbering schemes developed
22    I,     2. 10.  4|               increase significantly. Identification numbering should be as ubiquitous
23    I,     2. 10.  4|             settings, such as patient identification codes on wristbands.” 22~ ~
24   II,     5.  1.  1|          policies. Screening and case identification strategies allow, in some
25   II,     5.  3.  7|         linked chain of actions, from identification and invitation of the target
26   II,     5.  3.  7|             survival rates allows the identification of regions or countries
27   II,     5.  4.  2|             Plans for the prevention, identification and treatment of diabetes
28   II,     5.  4.  2|              specific national unique identification numbers, including the use
29   II,     5.  4.  2|           register, through a central identification number that can be used
30   II,     5.  5.  3|             and tries to get a better identification of adolescents at risk of
31   II,     5.  5.  3|               is represented by early identification and intervention with the
32   II,     5.  5.  3|               Prevention through Risk Identification, Management, and Education (
33   II,     5.  5.  3|              State in ASD as the case identification system is very weak and
34   II,     5.  5.  3|              of two or three. Earlier identification of children with ASD could
35   II,     5.  5.  3|              risk, the extent of case identification and the study design.~ ~
36   II,     5.  7.  7|               461-70.~Levin A (2001): Identification of patients and risk factors
37   II,     5.  9. FB|               requires a more precise identification of atopic individuals, even
38   II,     5.  9.  5|               requires a more precise identification of atopic individuals, even
39   II,     5. 11.  3|          young people themselves.~The identification of new metals as significant
40   II,     5. 12.  6|    transplantation is performed after identification and diagnosis of liver cancer
41   II,     5. 14.  6|         Europe, thus complicating the identification of these groups and the
42   II,     5. 15.  3|               causes the disease. The identification of at risk couples is hardly
43   II,     5. 15.  4|          improvement of knowledge and identification of RD; improvement of diagnosis
44   II,     7.  3.  4|             of road accidents for the identification and quantification of road
45   II,     7.  3.  4|                Home and leisure~ ~The identification of home and leisure accidents
46   II,     7.  4    |      reduction.~ ~This has led to the identification of the following seven priority
47   II,     8.  2.  1|       associated with access to care, identification of disease and treatment
48   II,     8.  2.  1|                or fragile X syndrome. Identification of a gene for an inherited
49   II,     9.  2.  4|               more important – is the identification of the relative importance
50   II,     9.  2.  6|         primary care to seek improved identification and measurement of the problem.~ ~
51   II,     9.  3.  2|                A key challenge is the identification of meaningful indicators
52   II,     9.  5.  4|             for further research. The identification and measurement of health-damaging
53  III,    10.  2.  4|              earlier and more precise identification of risk strata in families
54  III,    10.  2.  4|             the population (i.e., the identification of high, moderate and low
55  III,    10.  2.  5|           childhood and adult health. Identification of early developmental factors
56  III,    10.  3.  1|      Additionally, diagnosis and case identification may be more common in this
57  III,    10.  3.  1|         preventive activities and the identification of core issues of concern.
58  III,    10.  4.  2|           crucial areas;~· inadequate identification of emerging risks; and~·
59  III,    10.  4.  2|      considered as provisional.~ ~The identification of the origin of feed and
60  III,    10.  4.  2|           Europe, QPS will permit the identification of what is required to make
61  III,    10.  4.  2|       analysis of foods” and for “the identification of “emerging risks”~ ~Risk-benefit
62  III,    10.  4.  2|       following steps:~ ~· The hazard identification describes the adverse effects
63  III,    10.  4.  2|     assessment should include benefit identification, benefit characterisation (
64  III,    10.  4.  2|          procedure for emerging risks identification is being worked out by EFSA
65  III,    10.  4.  5|              data are available, site identification activities are generally
66  III,    10.  5.  2|             of monitoring and reduced identification (thereby leading to an under-reporting
67  III,    10.  5.  3|               equipment~- 90/269/EEC: identification and prevention of manual
68  III,    10.  5.  3|               machinery~- 2002/44/EC: identification and prevention of risks
69   IV,    12.  5    |     assessment by promoting the early identification of risks; analyse their
70   IV,    13.  7.  5|             policies through a better identification of risk groups. Recent technical